Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group

CONCLUSION: PET-2-positive residuals of AS-HL are mostly located in the mediastinum, and a majority of patients have few affected regions. The risk of progression was twofold higher in patients with more than two positive regions in PET-2.PMID:37735258 | DOI:10.1007/s00259-023-06431-w

Source: Molecular Medicine - September 21, 2023 Category: Molecular Biology Authors: Justin Ferdinandus Lutz van Heek Katrin Roth Markus Dietlein Hans-Theodor Eich Christian Baues Peter Borchmann Carsten Kobe Source Type: research